Fig. 5
Comparison of E-cad expression loss between TNBC and luminal subtype and HER2-enriched tumors. TNBC triple-negative breast cancer
Fig. 5 | World Journal of Surgical Oncology
Comparison of E-cad expression loss between TNBC and luminal subtype and HER2-enriched tumors. TNBC triple-negative breast cancer